Fluorouracil (5-FU) + Leucovorin / Folinic acid & Colorectal Cancer (CRC)

In the context of Fluorouracil (5-FU) + Leucovorin / Folinic acid & Colorectal Cancer (CRC), Fluorouracil (5-FU) + Leucovorin / Folinic acid is an established standard regimen for colorectal cancer, but the specific 2‑drug combination is not a standalone, branded product with its own FDA or EMA “combination” approval like a fixed‑dose co‑formulation. Instead, 5‑FU and leucovorin are each approved anticancer drugs, and their use together in colorectal cancer (e.g., FOLFOX, FOLFIRI, Mayo regimen) is an accepted, guideline‑based standard of care derived from trials and reflected in labels, clinical practice, and consensus documents (1)

The clinical phase II trial, identified as NCT0080791…